• Molecular NameOxybuprocaine
  • SynonymBenoxinate; Benoxinate HCL; Benoxinate hydrochloride; Dorsacaine hydrochloride; Oxbarukain; Oxibuprocainum; Oxibuprokain; Oxybucaine; Oxybuprocaine HCL; Oxybuprocaine hydrochloride; Oxyriprocaine
  • Weight308.422
  • Drugbank_IDDB00892
  • ACS_NO99-43-4
  • Show 3D model
  • LogP (experiment)4.38
  • LogP (predicted, AB/LogP v2.0)3.85
  • pkaN/A
  • LogD (pH=7, predicted)2.03
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.28
  • LogSw (predicted, AB/LogsW2.0)0.23
  • Sw (mg/ml) (predicted, ACD/Labs)0.14
  • No.of HBond Donors2
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds11
  • TPSA64.79
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA drug is used especially in ophthalmology and otolaryngology.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A